{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:38:53Z","timestamp":1792057133829,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.placenta.2017.03.021","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T17:34:21Z","timestamp":1490895261000},"page":"73-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Angiopoietin 2 in placentation and tumor biology: The yin and yang of vascular biology"],"prefix":"10.1016","volume":"56","author":[{"given":"Qiong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gendie E.","family":"Lash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2017.03.021_bib1","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","article-title":"Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis","volume":"87","author":"Suri","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.placenta.2017.03.021_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in\u00a0vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.placenta.2017.03.021_bib3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1096\/fj.03-1466com","article-title":"Biological characterization of angiopoietin-3 and angiopoietin-4","volume":"18","author":"Lee","year":"2004","journal-title":"FASEB. J."},{"key":"10.1016\/j.placenta.2017.03.021_bib4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.yexcr.2005.09.002","article-title":"Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling","volume":"312","author":"Eklund","year":"2006","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.placenta.2017.03.021_bib5","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1242\/dev.126.20.4569","article-title":"Interaction of the TEK and TIE receptor tyrosine kinases during cardiovascular development","volume":"126","author":"Puri","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.placenta.2017.03.021_bib6","doi-asserted-by":"crossref","first-page":"20126","DOI":"10.1074\/jbc.M500292200","article-title":"Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2","volume":"280","author":"Kim","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.placenta.2017.03.021_bib7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cardiores.2006.08.002","article-title":"Interaction between Tie receptors modulates angiogenic activity of angiopoietin 2 in endothelial progenitor cells","volume":"72","author":"Kim","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.placenta.2017.03.021_bib8","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1242\/jcs.03077","article-title":"Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization","volume":"119","author":"Bogdanovic","year":"2006","journal-title":"J.\u00a0Cell. Sci."},{"key":"10.1016\/j.placenta.2017.03.021_bib9","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1096\/fj.07-8487com","article-title":"Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival","volume":"21","author":"Yuan","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.placenta.2017.03.021_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1126\/science.277.5322.48","article-title":"Signaling vascular morphogenesis and maintenance","volume":"277","author":"Hanahan","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.placenta.2017.03.021_bib11","doi-asserted-by":"crossref","first-page":"11205","DOI":"10.1073\/pnas.172161899","article-title":"Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in\u00a0vivo","volume":"99","author":"Lobov","year":"2002","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.placenta.2017.03.021_bib12","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.bbrc.2014.08.096","article-title":"miRNA-dependent cross-talk between VEGF and Ang-2 in hypoxia-induced microvascular dysfunction","volume":"452","author":"Zhao","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.placenta.2017.03.021_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.placenta.2008.10.004","article-title":"Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy","volume":"30","author":"Schiessl","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2017.03.021_bib14","unstructured":"A. Robson, G.E. Lash, B.A. Innes, S.C. Robson, J.N. Bulmer, Uterine natural killer cells mediate dedifferentiation of spiral artery vascular smooth muscle cells in early human pregnancy. J. Leukoc. Biol. Under Revision."},{"key":"10.1016\/j.placenta.2017.03.021_bib15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF03401869","article-title":"The regulation and localization of angiopoietin-1, -2, and their receptor Tie2 in normal and pathologic human placentae","volume":"7","author":"Zhang","year":"2001","journal-title":"Mol. Med."},{"key":"10.1016\/j.placenta.2017.03.021_bib16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1053\/beog.2000.0138","article-title":"Angiogenesis and placental growth in normal and compromised pregnancies","volume":"14","author":"Ong","year":"2000","journal-title":"Baillieres Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.placenta.2017.03.021_bib17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/beog.2000.0139","article-title":"Angiogenesis and intrauterine growth restriction","volume":"14","author":"Ahmed","year":"2000","journal-title":"Baillieres Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.placenta.2017.03.021_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00404-015-3803-1","article-title":"Serum levels of ET-1, M30, and angiopoietins-1 and -2 in HELLP syndrome and preeclampsia compared to controls","volume":"293","author":"Karakus","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.placenta.2017.03.021_bib19","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3892\/etm.2015.2280","article-title":"Role of the angiopoietin\/Tie system in pregnancy (Review)","volume":"9","author":"Kappou","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.placenta.2017.03.021_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5468\/ogs.2015.58.1.10","article-title":"Midtrimester maternal plasma concentrations of angiopoietin 1, angiopoietin 2, and placental growth factor in pregnant women who subsequently develop preeclampsia","volume":"58","author":"Shim","year":"2015","journal-title":"Obstet. Gynecol. Sci."},{"key":"10.1016\/j.placenta.2017.03.021_bib21","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.placenta.2014.07.001","article-title":"Placental mRNA expression of angiopoietins (Ang)-1, Ang-2 and their receptor Tie-2 is altered in pregnancies complicated by preeclampsia","volume":"35","author":"Kappou","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2017.03.021_bib22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s13224-013-0388-0","article-title":"Circulating vascular growth factor (VEGF) Angiopoietin-1 (Angi-1) and soluble Tie-2 receptor in pregnancy complicated with pre-eclampsia: a prospective study","volume":"63","author":"Aref","year":"2013","journal-title":"J.\u00a0Obstet. Gynaecol. India"},{"key":"10.1016\/j.placenta.2017.03.021_bib23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ajog.2013.11.012","article-title":"Angiopoietin 1 and 2 serum concentrations in first trimester of pregnancy as biomarkers of adverse pregnancy outcomes","volume":"210","author":"Schneuer","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2017.03.021_bib24","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/S0002-9440(10)65089-4","article-title":"Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development","volume":"156","author":"Dunk","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.placenta.2017.03.021_bib25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tcm.2012.05.008","article-title":"Understanding the link between the placenta and future cardiovascular disease","volume":"21","author":"Siddiqui","year":"2011","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.placenta.2017.03.021_bib26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.placenta.2017.03.021_bib27","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.placenta.2005.12.006","article-title":"The uterine spiral arteries in human pregnancy: facts and controversies","volume":"27","author":"Pijnenborg","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2017.03.021_bib28","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1096\/fj.12-210310","article-title":"Uterine natural killer cells initiate spiral artery remodelling in human pregnancy","volume":"26","author":"Robson","year":"2012","journal-title":"FASEB. J."},{"key":"10.1016\/j.placenta.2017.03.021_bib29","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1189\/jlb.0406250","article-title":"Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy","volume":"80","author":"Lash","year":"2006","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.placenta.2017.03.021_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1189\/jlb.1A0815-351R","article-title":"Decidual macrophages: key regulators of vascular remodeling in human pregnancy","volume":"100","author":"Lash","year":"2016","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.placenta.2017.03.021_bib31","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/ejhg.2012.273","article-title":"Angiogenetic axis angiopoietins\/Tie2 and VEGF in familial breast cancer","volume":"21","author":"Danza","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.placenta.2017.03.021_bib32","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1158\/1078-0432.CCR-09-1924","article-title":"Angiopoietin-2 promotes disease progression of neuroendocrine tumors","volume":"16","author":"Detjen","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.placenta.2017.03.021_bib33","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.bjc.6605925","article-title":"Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy","volume":"103","author":"Goede","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.placenta.2017.03.021_bib34","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1158\/1078-0432.CCR-08-1615","article-title":"Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma","volume":"15","author":"Helfrich","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.placenta.2017.03.021_bib35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/cgt.2016.30","article-title":"Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis","volume":"23","author":"Li","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.placenta.2017.03.021_bib36","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.immuni.2013.09.014","article-title":"TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance","volume":"39","author":"Baghdadi","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.placenta.2017.03.021_bib37","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1073\/pnas.1525360113","article-title":"Ang-2\/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival","volume":"113","author":"Kloepper","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.placenta.2017.03.021_bib38","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1073\/pnas.1525349113","article-title":"Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages","volume":"113","author":"Peterson","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.placenta.2017.03.021_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.15252\/emmm.201505505","article-title":"Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma","volume":"8","author":"Scholz","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.placenta.2017.03.021_bib40","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ccell.2014.11.005","article-title":"Postsurgical adjuvant tumor therapy by combining anti-angiopoietin-2 and metronomic chemotherapy limits metastatic growth","volume":"26","author":"Srivastava","year":"2014","journal-title":"Cancer Cell."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400417302217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400417302217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:56:19Z","timestamp":1758909379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400417302217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":40,"alternative-id":["S0143400417302217"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2017.03.021","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiopoietin 2 in placentation and tumor biology: The yin and yang of vascular biology","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2017.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}